Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

S 2209

Known as: S-2209, S2209 cpd 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Australian guidelines recommend the tuberculin skin test (TST) as the preferred test for latent tuberculosis infection (LTBI… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Review
2013
Review
2013
  • O. Fuchs
  • Cardiovascular & hematological disorders drug…
  • 2013
  • Corpus ID: 36794356
Multiple myeloma (MM) remains an incurable disease, at least for the big majority of patients, in spite of the great progress… Expand
Highly Cited
2010
Highly Cited
2010
Inhibition of histone deacetylase (HDAC) is a promising mechanism for novel, anti‐myeloma agents. We investigated the effects of… Expand
2009
2009
Bortezomib is the first approved member of a new class of anti‐myeloma agents, the proteasome inhibitors. Further proteasome… Expand
2007
2007
Purpose: Multiple Myeloma (MM) is still an incurable disease. Patients become resistant to cytotoxic drugs and die of disease… Expand